| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.22 | 0.0001 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.21 | 0.0003 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.2 | 0.002 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.18 | 0.003 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.006 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.095 | 0.007 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |